Report #2832301

Received Mar 20, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: NY
Recovered: Unknown
Vaccinated: Mar 7, 2025
Onset: Mar 7, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
RSV	RSV (AREXVY)	GLAXOSMITHKLINE BIOLOGICALS	UNK	UNK	—

Symptoms (1)

Expired product administered

Symptom narrative

The product expired on 24 FEB 2025 and was administered on 7 MAR 2025; This non-serious case was reported by a physician via call center representative and described the occurrence of expired vaccine used in a patient who received RSVPreF3 adjuvanted (Arexvy) (expiry date 24-FEB-2025) for prophylaxis. On 07-MAR-2025, the patient received Arexvy. On 07-MAR-2025, an unknown time after receiving Arexvy, the patient experienced expired vaccine used (Verbatim: The product expired on 24 FEB 2025 and was administered on 7 MAR 2025). The outcome of the expired vaccine used was not applicable. Additional Information: GSK Receipt Date: 10-MAR-2025 The reporter was physician who stated that a patient accidentally received an expired dose of Arexvy. The product expired on 24th February 2025 and was administered on 07th March 2025 which led to expired vaccine used.